Home » Newsletters » BioWorld

BioWorld

June 23, 1994

View Archived Issues

SHEFFIELD GETS OPTION ON HIV VACCINE

INTERNEURON BUYS RESEARCH AND DEVELOPMENT COMPANY

IMRE CORP. GETS FIRST PURCHASE ORDER FROM BAXTER

APPOINTMENTS AND ADVANCEMENTS

GENSIA TESTS DRUG FOR CNS DISEASES

GENE THERAPISTS DEBUGGING TOP DNA DELIVERY VECTOR

SPARTA GROSSES $5.5M IN IPO

AD HOC RISK ASSESSMENT OF BIOTECH NO LONGER ACCEPTABLE

GENETICS INSTITUTE SUES ORTHO OVER EPO PATENT

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 17, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Mechanism underlying so-called idiopathic autism inception unveiled
BioWorld Science
Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.